HB 65: Stem Cells
GENERAL BILL by Clemons ; Pigman ; (CO-INTRODUCERS) Bush ; Casello ; Payne
Stem Cells; Establishes patient eligibility criteria & requirements relating to access to & use of investigational stem cell treatments; requires DOH to adopt rules; prohibits governmental interference in such treatments; requires institutional review boards to oversee treatments, keep records, & submit reports; prohibits purchase or sale of stem cells; provides penalties.
Effective Date: 7/1/2019
Last Action: 5/3/2019 House - Died in Health Quality Subcommittee
Bill Text: PDF
Last Action: 5/3/2019 House - Died in Health Quality Subcommittee
Bill Text: PDF
-
Bill History
Date Chamber Action 11/29/2018 House • Filed
1/3/2019 House • Referred to Health Quality Subcommittee; Health Care Appropriations Subcommittee; Health and Human Services Committee -HJ 27
3/5/2019 House • Introduced -HJ 27
5/3/2019 House • Indefinitely postponed and withdrawn from consideration
• Died in Health Quality Subcommittee
-
HB 65, Original Filed Version (Current Bill Version) Posted 11/29/2018 at 8:22 AM
Bill Text: PDF Analyses: None Related Bills (1)
Bill Number Subject Filed By Relationship Last Action and Location Track Bills S 954 Stem Cells Berman Similar Last Action: 5/3/2019 S Died in Health Policy 
Citations - Statutes (2)
Citation Catchline Location in Bill Location In Bill Help 385.301 Page 2 (pdf) 873.01 Purchase or sale of human organs and tissue prohibited. Page 6 (pdf)